Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development

Overview of attention for article published in Frontiers in immunology, October 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 6 X users

Readers on

mendeley: 11 Mendeley

Summary X

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 54,960 followers.

RT @PaperbirdsO: New article: Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor deve…

20 Oct 2022

Reply Repost Favourite

New article: Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development https://t.co/ilfzl71qgL #melanoma #oncology https://t.co/NsTe5DunBB

20 Oct 2022

Reply Repost Favourite

RT @hernangraffe: https://t.co/roGpCZPKkq

03 Oct 2022

Reply Repost Favourite

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development: Licensed L1-VLP-based immunizations against high-risk mucosal human papillomavirus (HPV) types have been a… #immunology https://t.co/QdHq

03 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.